Affiliations: Department of Occupational Therapy, University of
Illinois at Chicago, Chicago, IL, USA | Professor, Department of Occupational Therapy,
University of Illinois at Chicago, Chicago, IL, USA | Associate Professor of Occupational Therapy,
University of Illinois at Chicago, Chicago, IL, USA
Note: [] Address for correspondence: Brent Braveman, Ph.D., OTR/L, FAOTA,
Clinical Associate Professor, Department of Occupational Therapy, University of
Illinois at Chicago, M/C 811, 1919 W Taylor Street, Chicago, IL 60612, USA.
Tel.: +1 312 355 2656; Fax: +1 312 413 0256; E-mail: Bbravema@uic.edu
Abstract: It has been a little over one decade since the introduction of the
first protease inhibitor that ushered in new era of treatment for persons
living with human immunodeficiency virus (HIV) and Acquired Immune-Deficiency
Syndrome (AIDS). As of the end of 2003, an estimated 37.8 million people
worldwide were infected with the HIV. It is estimated that there are
850,000–950,000 persons in the United States living with human
immunodeficiency virus (HIV) and that the incident rate is new cases each year.
Since AIDS affects so many people of working age in the US, issues of
employment, work rehabilitation and AIDS in the workplace have all become major
concerns. The paper presents a review of the literature published during a ten
year period that is relevant to understanding the various needs and barriers
related to work as well as services designed to address them.
